2012
DOI: 10.1074/jbc.m112.366419
|View full text |Cite
|
Sign up to set email alerts
|

The Peroxisome Proliferator-activated Receptor γ (PPARγ) Controls Natural Protective Mechanisms against Lipid Peroxidation in Amyotrophic Lateral Sclerosis

Abstract: Background: The mechanism of motor neuron degeneration in amyotrophic lateral sclerosis (ALS) is poorly understood.Results: The peroxisome proliferator-activated receptor γ (PPARγ) can be activated by lipid peroxidation metabolites in ALS motor neurons, and this can prompt the expression of antioxidant enzymes.Conclusion: PPARγ can exert a direct protective effect in ALS motor neurons.Significance: PPARγ transcriptional co-activators may represent therapeutic targets in ALS.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
35
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 52 publications
(38 citation statements)
references
References 70 publications
3
35
0
Order By: Relevance
“…Luciferase enzyme reporter assay on intestinal tissues was performed as described in previous study(25). Luciferase enzyme activity in the tissue extract was measured by the Luciferase system, according to the manufacturer’s instructions (Promega).…”
Section: Methodsmentioning
confidence: 99%
“…Luciferase enzyme reporter assay on intestinal tissues was performed as described in previous study(25). Luciferase enzyme activity in the tissue extract was measured by the Luciferase system, according to the manufacturer’s instructions (Promega).…”
Section: Methodsmentioning
confidence: 99%
“…Gene and protein concentrations of PPAR-g, an FA-sensitive nuclear transcription factor that regulates lipid esterification and storage (41,42), were lower in the placentas of women with a high n-3:n-6 ratio (low n-6 FAs). Metabolites of the n-6 fatty acid arachidonate stimulate PPAR-g in the placenta and other tissues (43,44), suggesting that low n-6 may contribute to these effects. Although FAS expression was negatively correlated with maternal n-3 enrichment, FAS activity is very modest in the human placenta (45).…”
Section: Discussionmentioning
confidence: 99%
“…Thus, it remains unclear if PPARy agonists generally enhance peroxisome abundance or specifically alter the expression of selected peroxisomal genes. Since PPAR-γ agonists have been considered as potential therapeutic agents for a wide range of neurological diseases, including neurodegenerative and demyelinating diseases [7,87,97,155], it is a prerequisite to closely examine the proteomic alterations induced in peroxisomes in response to the drugs in order to avoid negative side effects by potentially impeding individual metabolic functions in the organelle.…”
Section: Other Ppar Family Membersmentioning
confidence: 99%